Title |
A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition
|
---|---|
Published in |
Molecular Neurodegeneration, February 2014
|
DOI | 10.1186/1750-1326-9-10 |
Pubmed ID | |
Authors |
Effie M Mitsis, Heidi A Bender, Lale Kostakoglu, Josef Machac, Jane Martin, Jennifer L Woehr, Margaret C Sewell, Amy Aloysi, Martin A Goldstein, Clara Li, Mary Sano, Sam Gandy |
Abstract |
Identification and quantification of fibrillar amyloid in brain using positron emission tomography (PET) imaging and Amyvid™ ([18 F] Amyvid, [18 F] florbetapir, 18 F-AV-45) was recently approved by the US Food and Drug Administration as a clinical tool to estimate brain amyloid burden in patients being evaluated for cognitive impairment or dementia. Imaging with [18 F] florbetapir offers in vivo confirmation of the presence of cerebral amyloidosis and may increase the accuracy of the diagnosis and likely cause of cognitive impairment (CI) or dementia. Most importantly, amyloid imaging may improve certainty of etiology in situations where the differential diagnosis cannot be resolved on the basis of standard clinical and laboratory criteria. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 88 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 17% |
Student > Bachelor | 13 | 14% |
Student > Ph. D. Student | 12 | 13% |
Researcher | 7 | 8% |
Other | 6 | 7% |
Other | 18 | 20% |
Unknown | 19 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 27% |
Psychology | 11 | 12% |
Nursing and Health Professions | 10 | 11% |
Neuroscience | 6 | 7% |
Agricultural and Biological Sciences | 3 | 3% |
Other | 10 | 11% |
Unknown | 26 | 29% |